F. Azem
Tel Aviv Sourasky Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by F. Azem.
Journal of Assisted Reproduction and Genetics | 2001
Dalit Ben-Yosef; Israel Yovel; Tamar Schwartz; F. Azem; Joseph B. Lessing; Ami Amit
AbstractPurpose: To assess the comparative efficacy of IVF medium (MediCult, with 5.2 mM glucose) and a glucose/phosphate-free medium, P1 (Irvine Scientific), and to investigate the influence of increasing the serum supplementation (synthetic serum substitute; SSS; Irvine Scientific) to P1 on embryo development and implantation. Methods: Patients were randomly assigned to IVF medium (Group 1, cycles n = 172) or P1 supplemented with 10% SSS (Group 2, cycles n = 229) according to the medium scheduled for use on the day of oocyte retrieval. Another 555 IVF consequent cycles (Group 3) were performed using increased SSS concentrations (20%) in P1 medium. Results and Conclusion: In this large series of IVF cycles, we herein demonstrate that significantly higher pregnancy and implantation rates were found when embryos were cultured in glucose/phosphate-free medium P1 supplemented with 20% SSS compared to supplementation with the lower SSS concentration and with IVF medium.
Journal of Assisted Reproduction and Genetics | 1999
Ariel Many; F. Azem; Joseph B. Lessing; Israel Yovel; Haim Yavetz; Ami Amit
Purpose:In vitro fertilization had been previously suggested by us as a means of “rescue” for patients with imminent ovarian hyperstimulation syndrome (OHSS) during treatment with human menopausal gonadotropin (hMG). We evaluated the pregnancy rate of rescued IVF cycles.Methods:During the years 1994–1995, women treated with hMG and at risk of developing OHSS were referred to our IVF unit. Their estradiol level was above 1500 pg/ml, and eight or more follicles were observed by ultrasonography In all the patients. These high responders were offered the option to undergo ovum aspiration. We report the pregnancy rate in this group of patients.Results:Thirty-nine women were referred to our unit for rescue IVF. Two were uneligible due to high progesterone concentrations. Thirty-seven women underwent ovum pickup and 32 had embryo transfer. The clinical pregnancy rate was 40% (13/32). Only two women had clinical OHSS.Conclusions:We suggest that rescue IVF may be considered in hMG cycles of high responders with imminent OHSS. Rescue IVF offers a high rate of conception, avoids high-order multiple pregnancy, and appears not to increase the risk of OHSS in these women.
Journal of Perinatal Medicine | 2011
Yaron Haimovich; Jessica Ascher-Landsberg; F. Azem; Dror Mandel; Francis B. Mimouni; Ariel Many
Abstract Objective: To estimate the influence of fetal growth restriction (FGR) on neonatal morbidity and mortality among premature discordant twin neonates. Study design: Our medical records (2002–2007) of preterm twins born at 24–37 weeks’ gestation were reviewed. Significant discordance was defined as >15% difference in birth weight. Small for gestational age (SGA) was defined as birth weight <10th percentile, and appropriate for gestational age (AGA) was between the 10th and 90th percentile, according to a twin and sex-adjusted gestational age nomogram. The SGA/AGA group comprised of one SGA twin and its AGA pair (30 pairs). Another group of non-SGA discordant twins was also evaluated (n=40 pairs, AGA/AGA). The morbidity and mortality rates were compared between the groups. Results: Of the selected outcome variables, the only ones in which the incidence was significantly lower for SGA neonates than their AGA pairs were respiratory distress syndrome (5 vs. 11, P=0.014), apnea (1 vs. 9, P=0.004) and the need for respiratory support (5 vs. 14, P=0.002). Anemia, erythropoietin therapy and hyperbilirubinemia were significantly higher in the SGA twin. All selected outcome variables had similar rates within the AGA/AGA pairs. Conclusion: FGR among premature discordant twin pairs is associated with significantly lower rates of respiratory morbidity and higher anemia and erythropoietin therapy rates. Overall morbidity is similar for discordant non-FGR twin pairs.
Human Reproduction | 1999
Dalit Ben-Yosef; Leah Yogev; Ron Hauser; Haim Yavetz; F. Azem; Israel Yovel; Joseph B. Lessing; Ami Amit
Human Reproduction | 2004
Yoni Cohen; Mira Malcov; Tamar Schwartz; N. Mey‐Raz; A. Carmon; T. Cohen; Joseph B. Lessing; Ami Amit; F. Azem
Human Reproduction | 1995
Eli Geva; Ami Amit; Lerner-Geva L; F. Azem; Israel Yovel; Joseph B. Lessing
Journal of Andrology | 2006
Ron Hauser; Leah Yogev; Gedalia Paz; Haim Yavetz; F. Azem; Joseph B. Lessing; Amnon Botchan
Human Reproduction | 1996
Asnat Groutz; Israel Yovel; Ami Amit; Yuval Yaron; F. Azem; Joseph B. Lessing
Journal of Assisted Reproduction and Genetics | 1993
F. Azem; Yuval Yaron; Amnon Botchan; Ami Amit; Israel Yovel; Menachem P. David; M. R. Peyser; Joseph B. Lessing
Human Reproduction | 1997
Haim Yavetz; Ron Hauser; Amnon Botchan; F. Azem; Israel Yovel; Joseph B. Lessing; Ami Amit; Leah Yogev